Sign in

CIK 0001549595 · Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
operating
EIN
270838048
Phone
(415) 660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ring Christine −$819K Chief Legal Officer sold 88% of stake
  2. GREGORY JULIA P −$529K Director sold 68% of stake
  3. Hansen Gwenn −$216K Chief Scientific Officer sold 6% of stake
  4. van Houte Hans −$149K Chief Financial Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-30 van Houte Hans Chief Financial Officer Sale −2,845 $23.38 $67K 44,927
2026-07-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −3,750 11,250
2026-07-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −2,858 20,009
2026-07-30 van Houte Hans Chief Financial Officer Option exercise · Restricted Stock Units −3,572 39,303
2026-07-30 Ring Christine Chief Legal Officer Option exercise +3,750 17,329
2026-07-30 Ring Christine Chief Legal Officer Option exercise +2,858 20,187
2026-07-30 Ring Christine Chief Legal Officer Option exercise +3,572 23,759
2026-07-30 Ring Christine Chief Legal Officer Sale −3,847 $23.38 $90K 19,912
2026-07-30 Ring Christine Chief Legal Officer Option exercise · Restricted Stock Units −3,750 11,250
2026-07-30 Ring Christine Chief Legal Officer Option exercise · Restricted Stock Units −2,858 20,009
2026-07-30 Ring Christine Chief Legal Officer Option exercise · Restricted Stock Units −3,572 39,303
2026-07-30 Hansen Gwenn Chief Scientific Officer Option exercise +3,750 118,755
2026-07-30 Hansen Gwenn Chief Scientific Officer Option exercise +2,858 121,613
2026-07-30 Hansen Gwenn Chief Scientific Officer Option exercise +3,572 125,185
2026-07-30 Hansen Gwenn Chief Scientific Officer Sale −3,847 $23.38 $90K 121,338
2026-07-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,750 11,250
2026-07-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −2,858 20,009
2026-07-30 Hansen Gwenn Chief Scientific Officer Option exercise · Restricted Stock Units −3,572 39,303
2026-07-02 Ring Christine Chief Legal Officer Option exercise 10b5-1 +5,221 $1.86 $10K 18,800
2026-07-02 Ring Christine Chief Legal Officer Option exercise 10b5-1 +5,787 $8.72 $50K 24,587

Page 4 of 20 · 381 trades